What Happened?
Shares of healthcare services company Agilon Health (NYSE: AGL) fell 7.6% in the afternoon session after the stock's weakness continued as the company provided its financial outlook at the Barclays 28th Annual Global Healthcare Conference, which included a forecast for rising costs in 2026.
During the presentation, agilon health stated that its cost trends were forecasted to grow 7.5% in 2026, with a net growth of 7%. This projection likely raised concerns among investors about the company's future profitability. While the company also shared some positive long-term goals, such as aiming for free cash flow break-even by 2027 and expecting a $125 million benefit from contracting improvements, the more immediate news of rising costs appeared to weigh on investor sentiment.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy agilon health? Access our full analysis report here, it’s free.
What Is The Market Telling Us
agilon health’s shares are extremely volatile and have had 82 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The previous big move we wrote about was 6 days ago when the stock dropped 13.5% on the news that a disappointing February jobs report revealed an unexpected contraction in employment, with significant job losses in the healthcare sector.
The U.S. economy lost 92,000 nonfarm payroll jobs, a sharp reversal from the 50,000 gain that economists had anticipated. The healthcare industry, typically a source of job growth, shed 28,000 positions. This was a stark contrast to its strong gains in the previous month. The discouraging data raised investor concerns about a potential economic slowdown, which could lead to reduced healthcare spending and demand for services. The Labor Department noted that the drop in healthcare hiring was partly due to recent strike activity.
agilon health is down 11.8% since the beginning of the year, and at $0.59 per share, it is trading 89.5% below its 52-week high of $5.68 from April 2025. Investors who bought $1,000 worth of agilon health’s shares at the IPO in April 2021 would now be looking at an investment worth $19.16.
ALSO WORTH WATCHING: Nvidia’s Quiet Partner. Nvidia’s chips cost a hundred grand. The connectors that make them work cost even more. One company makes them all.
Every AI server needs specialized infrastructure the chip companies don’t make. High-speed cables. Power connectors. Thermal sensors. This 90-year-old company built a monopoly on it. The AI boom just started. This stock is still flying under the radar. Claim The Stock Ticker Here for FREE.
